Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial.
van Straten CGJI, Caris C, Grimm MO, Colombel M, Muilwijk T, Martínez-Piñeiro L, Babjuk MM, Türkeri LN, Palou J, Patel A, Bjartell AS, Witjes WPJ, van der Heijden AG, Kiemeney LALM. van Straten CGJI, et al. Among authors: witjes wpj. Eur Urol Open Sci. 2023 Sep 12;56:15-24. doi: 10.1016/j.euros.2023.08.004. eCollection 2023 Oct. Eur Urol Open Sci. 2023. PMID: 37822514 Free PMC article.
Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group.
Witjes JA, v d Meijden AP, Collette L, Sylvester R, Debruyne FM, van Aubel A, Witjes WP. Witjes JA, et al. Urology. 1998 Sep;52(3):403-10. doi: 10.1016/s0090-4295(98)00212-x. Urology. 1998. PMID: 9730451 Clinical Trial.
A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life.
van Andel G, Fernandez de Moral P, Caris CT, Carpentier P, Wils J, de Bruin MJ, Witjes JA, Debruyne FM, Witjes WP. van Andel G, et al. World J Urol. 2003 Aug;21(3):177-82. doi: 10.1007/s00345-003-0342-3. Epub 2003 Jun 18. World J Urol. 2003. PMID: 12819912 Clinical Trial.
74 results